Aptose Biosciences Inc (APTO) insider trading

Every open-market stock purchase and sale by Aptose Biosciences Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: William G. Rice (CEO), $20K, 23 months ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $1.71 on Apr 1, 2025.

Recent APTO insider trades

DateInsiderTradeValue
Jun 30, 2026William G. Rice (CEO)Sold (not open market)$1.1M
Jun 30, 2026Bernd R. Seizinger (Insider)Sold (not open market)$29.2K
Jun 30, 2026Erich Platzer (Insider)Sold (not open market)$1.9K
Jun 30, 2026Rafael Bejar (Insider)Sold (not open market)$420
Jun 30, 2026Fletcher Payne (Insider)Sold (not open market)$382
Jun 30, 2026Denis R Burger (Insider)Sold (not open market)$120
Jun 30, 2026Warren Whitehead (Insider)Sold (not open market)$57
Jun 30, 2026Fletcher Payne (Insider)Sold (not open market)$38
Jun 30, 2026Warren Whitehead (Insider)Sold (not open market)—
Jun 30, 2026Warren Whitehead (Insider)Sold (not open market)—
Jun 30, 2026Warren Whitehead (Insider)Sold (not open market)—
Jun 30, 2026Warren Whitehead (Insider)Sold (not open market)—
Jun 30, 2026Warren Whitehead (Insider)Sold (not open market)—
Jun 30, 2026Warren Whitehead (Insider)Sold (not open market)—
Jun 30, 2026William G. Rice (CEO)Sold (not open market)—
Jun 30, 2026William G. Rice (CEO)Sold (not open market)—
Jun 30, 2026William G. Rice (CEO)Sold (not open market)—
Jun 30, 2026William G. Rice (CEO)Sold (not open market)—
Jun 30, 2026William G. Rice (CEO)Sold (not open market)—
Jun 30, 2026William G. Rice (CEO)Sold (not open market)—
Jun 30, 2026William G. Rice (CEO)Sold (not open market)—
Jun 30, 2026William G. Rice (CEO)Sold (not open market)—
Jun 30, 2026William G. Rice (CEO)Sold (not open market)—
Jun 30, 2026Erich Platzer (Insider)Sold (not open market)—
Jun 30, 2026Erich Platzer (Insider)Sold (not open market)—

Who's trading APTO

Get free alerts when an insider at Aptose Biosciences Inc files a new trade →